The Scientific Advisory Team at viTToria Biotherapeutics consists of esteemed experts who provide strategic guidance on the development and application of gene-edited cell therapies, focusing on enhancing the efficacy, safety, and utility of T-cell therapeutics. Their insights help drive the innovation and preclinical success of Senza5 Technology, ensuring the company's solutions address critical unmet medical needs.
View all